Posts Tagged ‘PHARMAQ Analytiq’
Scientists delve into rising incidence of mycobacteriosis on Norwegian salmon farms
Cases of mycobacteriosis, a serious disease affecting Atlantic salmon predominantly related to Mycobacterium salmoniphilum infections, appear to be on the increase in Norway.
Read MoreTackling jellyfish blooms affecting farmed fish in the British Isles
Tiny jellyfish have contributed to cases of gill disease in farmed Atlantic salmon in Scotland and Ireland in the past year, but early recognition and maintaining good general gill health are key to reducing the threat.
Read MoreRace to control bacterial disease which threatens Irish salmon production
The bacterium Piscirickettsia salmonis, which causes the disease salmonid rickettsial septicemia (SRS) in Atlantic salmon, is becoming an increasing concern on fish farms in Ireland.
Read MoreDistinct bacterial variants make winter ulcer diagnostics ever-more important
A complex genetic picture is posing problems for Norwegian salmon farmers managing stocks affected by winter ulcer.
Read MoreNovel parasiticide part of quest for long-lasting sea lice control in Chile
Currently, almost all Atlantic salmon producers affected by caligidosis have incorporated Alpha Flux as a useful and effective tool in their parasite-control strategy.
Read MoreTracking salmon through production offers new insight into gill disease
Gills coinfected with three or more pathogens is the “norm” in Western Norway’s salmon aquaculture, new field data suggests — but Neoparamoeba perurans is that which appears to be predominantly linked with gill disease.
Read MoreStudy sheds new light on Pasteurella infection in salmon and lumpsuckers
Atlantic salmon appear to be less susceptible to pasteurellosis than lumpsucker, the commonly used cleaner fish for the control of sea lice, the results of new PHARMAQ Analytiq-supported research suggest.
Read More